Modulation of the plasminogen activator/plasmin system in rat liver regenerating by recruitment of oval cells

Laboratory Investigation

Volumn 78, Issue 3, 1998, Pages 237-246

  Bisgaard, Hanne Cathrine ^a   Santoni Rugiu, Eric ^b   Nagy, Peter ^c   Thorgeirsson, Snorri S ^b  

^a ROSKILDE UNIVERSITY   (Denmark)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

N (2 FLUORENYL)ACETAMIDE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME INDUCTION; GROWTH STIMULATION; LIVER REGENERATION; NONHUMAN; PARTIAL HEPATECTOMY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RAT; STEM CELL;

2-ACETYLAMINOFLUORENE; ANIMALS; HEPATECTOMY; LIVER; LIVER REGENERATION; MALE; PLASMIN; PLASMINOGEN ACTIVATORS; RATS; RATS, INBRED F344; STEM CELLS;

EID: 0031884581     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Andreasen PA, Georg B, Lund LR, Riccio A, and Stacey SN (1990). Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocrinol 68:1-19.
2. Bisgaard HC and Thorgeirsson SS (1996). Hepatic regeneration: The role of regeneration in pathogenesis and chronic liver diseases. Clin Lab Med 16:325-339.
3. Bisgaard HC, Nagy P, Santoni-Rugiu E, and Thorgeirsson SS (1996). Proliferation, apoptosis, and induction of hepatic transcription factors are characteristics of the early response of biliary epithelial (oval) cells to chemical carcinogens. Hepatology 23:62-70.
4. Bucher NRL and Malt RA (1971). Regeneration of liver and kidney. Boston: Little, Brown and Co.
5. Bugge TH, Flick MJ, Danton MJS, Daugherty C, Rømer J, Danø K, Carmeliet P, Collen D, and Degen JL (1996a). Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of the receptor of tissue-type plasminogen activator. Proc Natl Acad Sci USA 93:5899-5904.
6. Bugge TH, Flick MJ, Daugherty CC, and Degen JL (1995a). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9:794-807.
7. Bugge TH, Kombrinck KW, Flick MW, Daugherty CC, Danton MJS, and Degen JL (1996b). Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87:709-719.
8. Bugge TH, Suh TT, Flick MJ, Daugherty CC, Rømer J, Solberg H, Ellis V, Danø K, and Degen JL (1995b). The receptor for the urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 270:16886-16894.
9. Carmeliet P, Schoojans L, Kieckens L, Beam B, Degen JL, Bronson R, DeVos R, Van den Oord JJ, Collen D, and Mulligan RC (1994a). Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368: 419-424.
10. Carmeliet P, Stassen L, Schoonjans L, Ream B, Van den Oord JJ, De Mol M, Mulligan RC, and Collen D (1994b). Plasminogen activator inhibitor-1 gene deficient mice: II -Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 92:2756-2760.
11. Cubellis MV, Nolli ML, Cassani G, and Blasi F (1986). Binding of single-chain prourokinase to the urokinase receptors of human U937 cells. J Biol Chem 261:15819-15822.
12. Cubellis MV, Wun T-C, and Blasi F (1990). Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9:1079-1085.
13. Dewerchin M, Nuffelen AV, Wallays G, Bouche A, Moons L, Carmeliet P, Mulligan RC, and Collen D (1996). Generation and characterization of urokinase receptor-deficient mice. J Clin Invest 97:370-878.
14. Engelhardt NV, Factor VM, Yasova AK, Poltoranina VS, Baranov VN, and Lasareva MN (1990). Common antigens of mouse oval and biliary epithelial cells: Expression on newly formed hepatocytes. Differentiation 45:29-37.
15. Evarts RP, Hu Z, Fujio K, Marsden ER, and Thorgeirsson SS (1993). Activation of the hepatic stem cell compartment in the rat: Role of transforming growth factor α, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Differ 4:555-561.
16. Evarts RP, Hu Z, Omori N, Omori M, Marsden ER, and Thorgeirsson SS (1996). Precursor-product relationship between oval cells and hepatocytes: Comparison between tritiated thymidine and bromodeoxyuridine as tracers. Carcinogenesis 17:2143-2151.
17. Farber E (1956). Similarities in the sequence of early histological changes induced in the liver by ethionine, 2-acetylaminofluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res 16:142-148.
18. Fort PH, Marty L, Piechaczyk M, Sabrouty SE, Danic C, Janteur P, and Blanchard JM (1985). Various rat tissue express only major mRNA species from glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucleic Acids Res 13:1431-1442.
19. Gold LI, Rostagna A, Frangione B, and Passalaris T (1992). Localization of the cleavage sites on fibronectin following digestion by urokinase. J Cell Biochem 50:441-452.
20. Hu Z, Evarts RP, Fujio K, Marsden ER, and Thorgeirsson SS (1993). Expression of hepatocyte growth factor and c- met during hepatic differentiation and liver development in the rat. Am J Pathol 142:1823-1829.
21. Jeffers M, Rong S, and Vande Woude GF (1996). Enhanced tumorigenecity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16:1115-1125.
22. Liu M-L, Mars WM, Zarnegar R, and Michalopoulos GK (1994). Collagenase pretreatment and the mitogenic effects of hepatocyte growth factor and transforming growth factor-α in adult rat liver. Hepatology 19:1521-1527.
23. Lucore CL, Fujii S, Wun T-C, Sobel BE, and Billadello JJ (1988). Regulation of the expression of type I plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. J Biol Chem 263:15845-15848.
24. Lund LR, Ellis V, Rønne E, Pyke C, and Danø K (1995). Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promotors in the human lung carcino cell line A549. Biochem J 310:345-352.
25. Lund LR, Rømer J, Rønne E, Ellis V, Blasi F, and Danø K (1991). Urokinase receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor-β1 in human A549 lung carcinoma cells. EMBO J 10:3399-3407.
26. Lyons R, Gentry LE, Purchio AF, and Moses HL (1990). Mechanism of activation of latent recombinant growth factor β1 by plasmin. J Cell Biol 110:1361-1367.
27. Mackay AR, Corbitt RH, Hartzler JL, and Thorgeirsson UP (1990). Basement membrane type iv collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 50:5997-6001.
28. Mars WM, Kim TH, Stolz DB, Liu ML, and Michalopoulos GK (1996). Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res 56:2837-2843.
29. Mars WM, Liu ML, Kitson RP, Goldfarb RH, Gabauer MK, and Michalopoulos GK (1995). Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 21:1695-1701.
30. Mars WM, Zarnegar R, and Michalopoulos GK (1993). Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 143:949-958.
31. Martinez-Hernandez A and Amenta PS (1993). Morphology, localization and origin of the hepatic extracellular matrix. In: Zern M and Reid L, editors. Extracellular matrix: Chemistry, biology, pathology. New York: Marcel Dekker, 255-327.
32. Michalopoulos GK and DeFrances MC (1997). Liver regeneration. Science 276:60-66.
33. Miyazawa K, Shimomura T, Naka D, and Kitamura N (1994). Proteolytic cleavage of hepatocyte growth factor in response to injury. J Biol Chem 269:8966-8970.
34. Nagy P, Bisgaard HC, Santoni-Rugiu E, and Thorgeirsson SS (1996). In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene. Hepatology 23:71-79.
35. Nagy P, Bisgaard HC, and Thorgeirsson SS (1994). Expression of hepatic transcription factors during liver development and oval cell differentiation. J Cell Biol 126:223-233.
36. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouch H, Blasi F, and Comoglio PM (1992). Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/ scatter factor. EMBO J 11:4825-4833.
37. Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F, and Comoglio PM (1995). Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem 270:603-611.
38. Pepper MS, Belin D, Montesano R, Orci L, and Vassalli J-D (1990). Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111:743-755.
39. Pepper MS, Matsumoto K, Nakamura T, Orci L, and Montesano R (1992). Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madine-Darby canine kidney epithelial cells. J Biol Chem 267:20493-20496.
40. Rubin EM, Martin AA, Thung SN, and Gerber MA (1995). Morphometric and immunohistochemical characterization of human liver regeneration. Am J Pathol 147:397-404.
41. Rutenberg AM, Kim H, Fischbein IW, Hanker JS, Waserkrug HL, and Seligman AM (1969). Histochemical and ultrastructure demonstration of γ-glutamyltranspeptidase activity. J Histochem Cytochem 17:517-526.
42. Saksela O and Rifkin DB (1988). Cell-associated plasminogen activation: Regulation and physiological functions. Ann Rev Cell Biol 4:93-126.
43. Sato Y, Tsuboi R, Lyons R, Moses H, and Rifkin DB (1990). Characterization of the activation of the latent TGF-β by co-cultures of endothelial cells and pericytes of smooth muscle cells: A self regulating system. J Cell Biol 111:757-763.
44. Sigal SH, Brill S, Reid LM, Zvibel I, Gupta S, Hixson D, Faris R, and Holst PA (1994). Characterization and enrichment of fetal rat hepatoblasts by immunoadsorption ("panning") and fluorescence activated sorting. Hepatology 19:999-1006.
45. Smedsrod B and Pertoft H (1985). Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of percoll centrifugation and selective adherence. J Leukoc Biol 38:213-230.
46. Sobczak J, Tournier MF, Lotti AM, and Duguet M (1989). Gene expression in regenerating liver in relation to cell proliferation and stress. Eur J Biochem 180:49-53.
47. Thornton AJ, Bruzdzinski CJ, Raper AE, and Gelehrter TD (1994). Plasminogen activator inhibitor-1 is an immediate early gene in the regenerating liver. Cancer Res 54:1337-1343.
48. Vassalli J-D, Sappino AP, and Belin D (1991). The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072.
49. Zeheb R and Gelehrter TD (1988). Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 73:459-469.